Medidata Solutions, Inc. (MDSO): Vries Glen Michael De , President of Medidata Solutions, Inc. sold 7,500 shares on Jun 9, 2016. The Insider selling transaction was reported by the company on Jun 13, 2016 to the Securities and Exchange Commission. The shares were sold at $47.66 per share for a total value of $357,450.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 3, 2016, Tarek Sherif (Chairman & CEO) sold 7,500 shares at $45.90 per share price.On Jun 2, 2016, Robert Taylor (director) sold 3,752 shares at $45.03 per share price.Also, On May 26, 2016, Neil M Kurtz (director) sold 5,937 shares at $44.96 per share price.On May 26, 2016, Steven Isaac Hirschfeld (Vice Chairman) sold 10,000 shares at $44.94 per share price.
Shares of Medidata Solutions Inc (MDSO) ended Friday, Jun 10, 2016 session in red amid volatile trading. The shares closed down -0.76 points or -1.60% at $46.79 with 3,53,990 shares getting traded. Post opening the session at $46.92, the shares hit an intraday low of $46.69 and an intraday high of $48.09 and the price vacillated in this range throughout the day. The company has a market cap of $2,681 M and the number of outstanding shares has been calculated to be 5,72,96,821 shares. The 52-week high of Medidata Solutions Inc is $61.308 and the 52-week low is $30.22.
Company has been under the radar of several Street Analysts.Medidata Solutions Inc is Downgraded by Jefferies to Underperform. Earlier the firm had a rating of Hold on the company shares. The Rating was issued on Apr 26, 2016.Medidata Solutions Inc is Initiated by Leerink Partners to Mkt Perform. The Rating was issued on Apr 26, 2016.Medidata Solutions Inc is Reiterated by Topeka Capital Markets to Buy and the brokerage firm has raised the Price Target to $ 51 from a previous price target of $44 .The Rating was issued on Apr 22, 2016.Medidata Solutions Inc is Reiterated by Needham to Buy and the brokerage firm has raised the Price Target to $ 57 from a previous price target of $45 .The Rating was issued on Apr 22, 2016.Medidata Solutions Inc is Reiterated by Topeka Capital Markets to Buy and the brokerage firm has raised the Price Target to $ 44 from a previous price target of $42 .The Rating was issued on Apr 5, 2016.
Medidata Solutions Inc. (Medidata) provides cloud-based solutions for life sciences. The Company’s solutions are Medidata Rave an electronic data capture (EDC) and clinical data management system (CDMS) solution; Medidata CTMS a clinical trial management solution; Medidata Designer a protocol design tool; Medidata Insights which offer clinical business analytics and metrics; Medidata Balance a randomization and trial supply management solution; Medidata Patient Cloud an electronic patient-reported outcome (ePRO) application; Medidata Grants Manager which develops and manages trial budgets; Medidata contract research organizations (CRO) Contractor an analytics tool; Medidata SQM a set of cloud-based site quality management dashboards; Medidata Coder a medical coding and synonym management solution; Medidata Safety Gateway which collects and transmits events and related data from the EDC system and Medidata Targeted SDV which implements risk-based monitoring strategies.